[Asia Economy Reporter Geum Bo-ryeong] Jetema announced on the 24th that it has acquired a domestic patent right related to 'culture medium composition.'
Jetema explained, "This medium is free of animal-derived ingredients and major allergens, allowing the botulinum toxin-producing strain to reach its maximum growth in a short time. This induces a reduction in production time and cost in the botulinum toxin production process."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
